Results 271 to 280 of about 7,856,482 (335)
Molecular Oncology, EarlyView.A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Anais Brasileiros de Dermatologia - Impact Factor and CiteScore for 2023. [PDF]
An Bras DermatolMarques SA +3 more
europepmc +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Molecular Oncology, EarlyView.Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Impact Factor for Journals Specializing in Dental Anesthesiology. [PDF]
Anesth ProgSanuki T, Tsukimoto S, Kuroda H, Kido K.
europepmc +1 more source
Integrating AI in Clinical Education: Evaluating General Practice Residents’ Proficiency in Distinguishing AI-Generated Hallucinations and Its Impacting Factors [PDF]
Jiacheng Zhou +11 more
openalex +1 more source
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
The impact of source burstiness on buffer performance: the Burst Factor [PDF]
, 2008 Bruneel, Herwig, Steyaert, Bart
core +1 more source